SCHEMBL24729704

SCHEMBL24729704

CNc1cc(NCc2cn3cc(C4CC4)ccc3n2)ncn1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
METTL3 Q86U44 1/20 0.44
KLKB1 P03952 18/20 0.42
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24729486 0.88 METTL3 (0.42) METTL3KLKB1
SCHEMBL29927404 0.88 METTL3 (0.42) METTL3KLKB1
SCHEMBL29305425 0.87 METTL3 (0.46) METTL3KLKB1
SCHEMBL29926787 0.87 METTL3 (0.44) METTL3KLKB1
SCHEMBL24729470 0.87 METTL3 (0.44) METTL3KLKB1
SCHEMBL29927129 0.87 METTL3 (0.44) METTL3KLKB1
SCHEMBL24729484 0.87 METTL3 (0.44) METTL3KLKB1
SCHEMBL24729620 0.87 METTL3 (0.44) METTL3KLKB1
SCHEMBL24729466 0.87 METTL3 (0.44) METTL3KLKB1KDM4ETP53
SCHEMBL29879114 0.87 METTL3 (0.44) METTL3KLKB1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022197758-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed
WO-2022197755-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed